Following encouraging clinical data , retatrutide, a novel peptide treatment for treating non-insulin dependent diabetes , has obtained regulatory approval from the Healthcare and Regulatory Agency (MHRA https://zoyahoss706425.tinyblogging.com/retatrutide-compound-peptide-uk-approval-and-availability-85384069